BACKGROUND: Usher Syndrome type II (USH2) is an autosomal recessive disorder, characterized by moderate to severe hearing impairment and retinitis pigmentosa (RP). Among the three genes implicated, mutations in the USH2A gene account for 74-90% of the USH2 cases. METHODS: To identify the genetic cause of the disease and determine the frequency of USH2A mutations in a cohort of 88 unrelated USH Spanish patients, we carried out a mutation screening of the 72 coding exons of this gene by direct sequencing. Moreover, we performed functional minigene studies for those changes that were predicted to affect splicing. RESULTS: As a result, a total of 144 DNA sequence variants were identified. Based upon previous studies, allele frequencies, segregation analysis, bioinformatics' predictions and in vitro experiments, 37 variants (23 of them novel) were classified as pathogenic mutations. CONCLUSIONS: This report provide a wide spectrum of USH2A mutations and clinical features, including atypical Usher syndrome phenotypes resembling Usher syndrome type I. Considering only the patients clearly diagnosed with Usher syndrome type II, and results obtained in this and previous studies, we can state that mutations in USH2A are responsible for 76.1% of USH2 disease in patients of Spanish origin.
BACKGROUND:Usher Syndrome type II (USH2) is an autosomal recessive disorder, characterized by moderate to severe hearing impairment and retinitis pigmentosa (RP). Among the three genes implicated, mutations in the USH2A gene account for 74-90% of the USH2 cases. METHODS: To identify the genetic cause of the disease and determine the frequency of USH2A mutations in a cohort of 88 unrelated USH Spanish patients, we carried out a mutation screening of the 72 coding exons of this gene by direct sequencing. Moreover, we performed functional minigene studies for those changes that were predicted to affect splicing. RESULTS: As a result, a total of 144 DNA sequence variants were identified. Based upon previous studies, allele frequencies, segregation analysis, bioinformatics' predictions and in vitro experiments, 37 variants (23 of them novel) were classified as pathogenic mutations. CONCLUSIONS: This report provide a wide spectrum of USH2A mutations and clinical features, including atypical Usher syndrome phenotypes resembling Usher syndrome type I. Considering only the patients clearly diagnosed with Usher syndrome type II, and results obtained in this and previous studies, we can state that mutations in USH2A are responsible for 76.1% of USH2 disease in patients of Spanish origin.
Authors: Terri L McGee; Babak Jian Seyedahmadi; Meredith O Sweeney; Thaddeus P Dryja; Eliot L Berson Journal: J Med Genet Date: 2010-05-27 Impact factor: 6.318
Authors: Inga Ebermann; Hendrik P N Scholl; Peter Charbel Issa; Elvir Becirovic; Jürgen Lamprecht; Bernhard Jurklies; José M Millán; Elena Aller; Diana Mitter; Hanno Bolz Journal: Hum Genet Date: 2006-12-15 Impact factor: 4.132
Authors: J D Eudy; M D Weston; S Yao; D M Hoover; H L Rehm; M Ma-Edmonds; D Yan; I Ahmad; J J Cheng; C Ayuso; C Cremers; S Davenport; C Moller; C B Talmadge; K W Beisel; M Tamayo; C C Morton; A Swaroop; W J Kimberling; J Sumegi Journal: Science Date: 1998-06-12 Impact factor: 47.728
Authors: Ronald J E Pennings; Heleen Te Brinke; Michael D Weston; Annemarie Claassen; Dana J Orten; Henriëtte Weekamp; Annelies Van Aarem; Patrick L M Huygen; August F Deutman; Lies H Hoefsloot; Frans P M Cremers; Cor W R J Cremers; William J Kimberling; Hannie Kremer Journal: Hum Mutat Date: 2004-08 Impact factor: 4.878
Authors: Elena Aller; Carmen Nájera; José María Millán; Juan S Oltra; Herminio Pérez-Garrigues; Concepción Vilela; Amparo Navea; Magdalena Beneyto Journal: Eur J Hum Genet Date: 2004-05 Impact factor: 4.246
Authors: Frans P M Cremers; William J Kimberling; Maigi Külm; Arjan P de Brouwer; Erwin van Wijk; Heleen te Brinke; Cor W R J Cremers; Lies H Hoefsloot; Sandro Banfi; Francesca Simonelli; Johannes C Fleischhauer; Wolfgang Berger; Phil M Kelley; Elene Haralambous; Maria Bitner-Glindzicz; Andrew R Webster; Zubin Saihan; Elfride De Baere; Bart P Leroy; Giuliana Silvestri; Gareth J McKay; Robert K Koenekoop; Jose M Millan; Thomas Rosenberg; Tarja Joensuu; Eeva-Marja Sankila; Dominique Weil; Mike D Weston; Bernd Wissinger; Hannie Kremer Journal: J Med Genet Date: 2006-09-08 Impact factor: 6.318
Authors: Rosalie M Nolen; Robert B Hufnagel; Thomas B Friedman; Amy E Turriff; Carmen C Brewer; Christopher K Zalewski; Kelly A King; Talah T Wafa; Andrew J Griffith; Brian P Brooks; Wadih M Zein Journal: Ophthalmic Genet Date: 2020-05-06 Impact factor: 1.803
Authors: Rachel L Paterson; John N De Roach; Terri L McLaren; Alex W Hewitt; Ling Hoffmann; Tina M Lamey Journal: Mol Vis Date: 2012-07-25 Impact factor: 2.367
Authors: Eva Lenassi; Ajoy Vincent; Zheng Li; Zubin Saihan; Alison J Coffey; Heather B Steele-Stallard; Anthony T Moore; Karen P Steel; Linda M Luxon; Elise Héon; Maria Bitner-Glindzicz; Andrew R Webster Journal: Eur J Hum Genet Date: 2015-02-04 Impact factor: 4.246
Authors: Kristy Lee; Jonathan S Berg; Laura Milko; Kristy Crooks; Mei Lu; Chris Bizon; Phillips Owen; Kirk C Wilhelmsen; Karen E Weck; James P Evans; Seema Garg Journal: Am J Ophthalmol Date: 2015-04-22 Impact factor: 5.258
Authors: Gema García-García; Thomas Besnard; David Baux; Christel Vaché; Elena Aller; Sue Malcolm; Mireille Claustres; Jose M Millan; Anne-Françoise Roux Journal: Mol Vis Date: 2013-02-13 Impact factor: 2.367
Authors: Heather B Steele-Stallard; Polona Le Quesne Stabej; Eva Lenassi; Linda M Luxon; Mireille Claustres; Anne-Francoise Roux; Andrew R Webster; Maria Bitner-Glindzicz Journal: Orphanet J Rare Dis Date: 2013-08-08 Impact factor: 4.123
Authors: Elena Aller; Ana V Sánchez-Sánchez; Javier U Chicote; Gema García-García; Patricia Udaondo; Laura Cavallé; Marina Piquer-Gil; Antonio García-España; Manuel Díaz-Llopis; José M Millán; José L Mullor Journal: PLoS One Date: 2013-09-23 Impact factor: 3.240
Authors: Thomas Besnard; Gema García-García; David Baux; Christel Vaché; Valérie Faugère; Lise Larrieu; Susana Léonard; Jose M Millan; Sue Malcolm; Mireille Claustres; Anne-Françoise Roux Journal: Mol Genet Genomic Med Date: 2013-07-10 Impact factor: 2.183